Esperion Therapeutics Inc. logo

Esperion Therapeutics Inc. (0ET)

Market Closed
3 Jun, 20:00
XSTU XSTU
2. 6780
+0.006
+0.22%
- Market Cap
- P/E Ratio
- Div Yield
200 Volume
-1.97 Eps
2.672
Previous Close
Add Transaction
Day Range
2.646 2.686
Year Range
0.779 3.547
Want to track 0ET and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Name Time Cons. EPS Eps
Esperion Therapeutics Inc. logo
0ET Esperion Therapeutics Inc.
4 May 2026
-
-
Esperion Therapeutics Inc. logo
0ET Esperion Therapeutics Inc.
3 Mar 2026
0.28
-
Esperion Therapeutics Inc. logo
0ET Esperion Therapeutics Inc.
6 Nov 2025
-
-
Esperion Therapeutics Inc. logo
0ET Esperion Therapeutics Inc.
11 Aug 2025
-
-
Esperion Therapeutics Inc. logo
0ET Esperion Therapeutics Inc.
5 May 2025
-
-
Esperion Therapeutics Inc. logo
0ET Esperion Therapeutics Inc.
25 Feb 2025
-
-
Esperion Therapeutics Inc. logo
0ET Esperion Therapeutics Inc.
5 Nov 2024
-
-
Esperion Therapeutics Inc. logo
0ET Esperion Therapeutics Inc.
30 Jul 2024
-
-
Esperion Therapeutics Inc. logo
0ET Esperion Therapeutics Inc.
20 May 2024
-
-
Esperion Therapeutics Inc. logo
0ET Esperion Therapeutics Inc.
25 Mar 2024
-
-
Esperion Therapeutics Inc. logo
0ET Esperion Therapeutics Inc.
19 Feb 2024
-
-
Esperion Therapeutics Inc. logo
0ET Esperion Therapeutics Inc.
30 Oct 2023
-
-

0ET Earnings Reports FAQ

What is the earnings per share (EPS) for 0ET?

The current EPS is -1.97.

What is the company's earnings growth rate?

Esperion Therapeutics Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.

When is the next earnings release date?

Esperion Therapeutics Inc has not announced its next earnings release date.

What were the most recent quarterly earnings?

The most recent quarterly earnings for Esperion Therapeutics Inc are not available at this time.

What is the price-to-earnings (P/E) ratio?

There is no P/E ratio for 0ET at this time, as Esperion Therapeutics Inc has no recent EPS data to calculate it.